The Classroom Check-up: A Classwide Teacher Consultation Model for Increasing Praise and Decreasing Disruptive Behavior

por Reinke, Wendy M., Lewis-Palmer, Teri, Merrell, Kenneth
Publicado 2008

Radiation biology considerations of proton therapy for gastrointestinal cancers

por Beltran, Chris, Schultz, Heather L., Anand, Aman, Merrell, Kenneth
Publicado en J Gastrointest Oncol (2020)

RT-28 INSTITUTIONAL REVIEW OF GAMMA KNIFE RADIOSURGERY IN PRIMARY AND RECURRENT HIGH-GRADE GLIOMAS

por Planchard, Ryan, Merrell, Kenneth, Thalacker, Steve, Parney, Ian, Laack, Nadia
Publicado en Neuro Oncol (2014)

Radiation and immunotherapy: emerging mechanisms of synergy

por Breen, William G., Leventakos, Konstantinos, Dong, Haidong, Merrell, Kenneth W.
Publicado en J Thorac Dis (2020)

RTHP-30. DOES THE TEMPORAL LOBECTOMY CAVITY NEED TO BE IRRADIATED? PATTERNS OF RECURRENCE AND IMPLICATIONS FOR POSTOPERATIVE RADIATION TREATMENT FIELD DESIGN FOR TEMPORAL LOBE GLIO...

por Teyateeti, Achiraya, Geno, Connie, Brown, Paul, Jethwa, Krishan, Stafford, Scott, Laack, Nadia, Mahajan, Anita, Yan, Elizabeth, Parney, Ian, Merrell, Kenneth
Publicado en Neuro Oncol (2019)

Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non–small cell lung cance...

por Breen, William G., Merrell, Kenneth W., Mansfield, Aaron S., Wigle, Dennis A., Garces, Yolanda I., Park, Sean S., Olivier, Kenneth R., Hallemeier, Christopher L.
Publicado en Adv Radiat Oncol (2016)

Stereotactic body radiotherapy for primary and metastatic liver tumors — the Mayo Clinic experience

por Merrell, Kenneth W., Johnson, Jedediah E., Mou, Benjamin, Barney, Brandon M., Nelson, Kathryn E., Mayo, Charles S., Haddock, Michael G., Hallemeier, Christopher L., Olivier, Kenneth R.
Publicado en J Radiosurg SBRT (2016)

Does the dural resection bed need to be irradiated? Patterns of recurrence and implications for postoperative radiotherapy for temporal lobe gliomas

por Teyateeti, Achiraya, Geno, Connie S, Stafford, Scott S, Mahajan, Anita, Yan, Elizabeth S, Merrell, Kenneth W, Laack, Nadia N, Parney, Ian F, Brown, Paul D, Jethwa, Krishan R
Publicado en Neurooncol Pract (2020)

Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC

por Arnett, Andrea L.H., Mou, Benjamin, Owen, Dawn, Park, Sean S., Nelson, Katy, Hallemeier, Christopher L., Sio, Terence, Garces, Yolanda I., Olivier, Kenneth R., Merrell, Kenneth W.
Publicado en Adv Radiat Oncol (2019)

Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related a...

por Jethwa, Krishan R., Tryggestad, Erik J., Whitaker, Thomas J., Giffey, Broc T., Kazemba, Bret D., Neben-Wittich, Michelle A., Merrell, Kenneth W., Haddock, Michael G., Hallemeier, Christopher L.
Publicado en Adv Radiat Oncol (2018)

Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and Size

por Leiting, Jennifer L., Bergquist, John R., Hernandez, Matthew C., Merrell, Kenneth W., Folpe, Andrew L., Robinson, Steven I., Nagorney, David M., Truty, Mark J., Grotz, Travis E.
Publicado en Sarcoma (2018)

Prediction of severe lymphopenia during chemoradiotherapy for esophageal cancer: development and validation of a pretreatment nomogram

por van Rossum, Peter S.N., Deng, Wei, Routman, David M., Liu, Amy Y., Xu, Cai, Shiraishi, Yutaka, Peters, Max, Merrell, Kenneth W., Hallemeier, Christopher L., Mohan, Radhe, Lin, Steven H.
Publicado en Pract Radiat Oncol (2019)

Clinical Implementation of Preoperative Short-Course Pencil Beam Scanning Proton Therapy for Patients With Rectal Cancer

por Jeans, Elizabeth B., Jethwa, Krishan R., Harmsen, William S., Neben-Wittich, Michelle, Ashman, Jonathan B., Merrell, Kenneth W., Giffey, Broc, Ito, Shima, Kazemba, Bret, Beltran, Chris, Haddock, Michael G., Hallemeier, Christopher L.
Publicado en Adv Radiat Oncol (2020)

A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer

por Routman, David M., Garant, Aurelie, Lester, Scott C., Day, Courtney N., Harmsen, William S., Sanheuza, Cristobal T., Yoon, Harry H., Neben-Wittich, Michelle A., Martenson, James A., Haddock, Michael G., Hallemeier, Christopher L., Merrell, Kenneth W.
Publicado en Adv Radiat Oncol (2019)

Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience

por Breen, William G., Garces, Yolanda I., Olivier, Kenneth R., Park, Sean S., Merrell, Kenneth W., Nichols, Francis C., Peikert, Tobias D., Molina, Julian R., Mansfield, Aaron S., Roden, Anja C., Blackmon, Shanda H., Wigle, Dennis A.
Publicado en Front Oncol (2020)

Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancer

por Jethwa, Krishan R., Sannapaneni, Shilpa, Mullikin, Trey C., Harmsen, William S., Petersen, Molly M., Antharam, Phanindra, Laughlin, Brady, Mahipal, Amit, Halfdanarson, Thorvardur R., Merrell, Kenneth W., Neben-Wittich, Michelle, Sio, Terence T., Haddock, Michael G., Hallemeier, Christopher L.
Publicado en J Gastrointest Oncol (2020)

Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma

por Leng, Xuefeng, Wei, Shiyou, Mei, Jiandong, Deng, Senyi, Yang, Zhenyu, Liu, Zheng, Guo, Chenglin, Deng, Yulan, Xia, Liang, Cheng, Jiahan, Zhao, Kejia, Gan, Fanyi, Li, Chuan, Merrell, Kenneth W., Molina, Julian R., Metro, Giulio, Liu, Lunxu
Publicado en Transl Lung Cancer Res (2021)

Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience

por Jethwa, Krishan R., Day, Courtney N., Sandhyavenu, Harigopal, Gonuguntla, Karthik, Harmsen, William S., Breen, William G., Routman, David M., Garda, Allison E., Hubbard, Joleen M., Halfdanarson, Thorvardur R., Neben-Wittich, Michelle A., Merrell, Kenneth W., Hallemeier, Christopher L., Haddock, Michael G.
Publicado en Clin Transl Radiat Oncol (2021)

Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

por Kowalchuk, Roman O., Lester, Scott C., Graham, Rondell P., Harmsen, William S., Zhang, Lizhi, Halfdanarson, Thorvardur R., Smoot, Rory L., Gits, Hunter C., Ma, Wen Wee, Owen, Dawn, Mahipal, Amit, Miller, Robert C., Wittich, Michelle A. Neben, Cleary, Sean P., McWilliams, Robert R., Haddock, Michael G., Hallemeier, Christopher L., Truty, Mark J., Merrell, Kenneth W.
Publicado en Front Oncol (2021)